-
1
-
-
0344856933
-
The molecular bases of blood coagulation
-
Hoffman R, Benz E, Shattil S, Furie B, Cohen H Ed. London: Churchill
-
Furie B, Furie BC. The molecular bases of blood coagulation. In: Hoffman R, Benz E, Shattil S, Furie B, Cohen H Ed. Hematologyc basic principles and practice. 3rd ed. London: Churchill: 1991; p. 1213.
-
(1991)
Hematologyc Basic Principles and Practice. 3rd Ed.
, pp. 1213
-
-
Furie, B.1
Furie, B.C.2
-
2
-
-
4243998299
-
Fisiología de la hemostasia. En manual de hemostasia y trombosis
-
Kordich L, et al. (eds)
-
Sánchez Avalos JC. Fisiología de la hemostasia. En Manual de Hemostasia y Trombosis. Kordich L, et al. (eds) Buenos Aires: 000; 1990 p. 3-17.
-
(1990)
Buenos Aires
, pp. 3-17
-
-
Sánchez Avalos, J.C.1
-
3
-
-
0000194758
-
Thrombin generation, an essential step an haemostasis and thrombosis
-
A. Bloom et al (eds). Edinburg: Churchill Livingstone
-
Hemker HC. Thrombin generation, an essential step an haemostasis and thrombosis. In: Haemostasis and Thrombose. A. Bloom et al (eds) Edinburg: Churchill Livingstone 1993; p 477-90.
-
(1993)
Haemostasis and Thrombose
, pp. 477-490
-
-
Hemker, H.C.1
-
4
-
-
0029114470
-
Thrombin functions and antithrombotic intervention
-
Fenton JW II. Thrombin functions and antithrombotic intervention. Thromb Haemost 1995; 74 (1): 493-8.
-
(1995)
Thromb Haemost
, vol.74
, Issue.1
, pp. 493-498
-
-
Fenton J.W. II1
-
5
-
-
0029093005
-
Thrombin specificity
-
Guillin MC, Bezeaud A, Bouton MC, Jandrot-Perrus M. Thrombin specificity Thromb Haemost 1995; 74 (1): 129-33.
-
(1995)
Thromb Haemost
, vol.74
, Issue.1
, pp. 129-133
-
-
Guillin, M.C.1
Bezeaud, A.2
Bouton, M.C.3
Jandrot-Perrus, M.4
-
6
-
-
0000493337
-
The inhibition of blood clotting. An unidentified substance which acts in conjunction with heparin to prevent conversion of prothrombin to thrombin
-
Brinkhous KM, Smith HP, Warner ED, Seegers WH. The inhibition of blood clotting. An unidentified substance which acts in conjunction with heparin to prevent conversion of prothrombin to thrombin. Am J Physiol 1939; 125: 683-7.
-
(1939)
Am J Physiol
, vol.125
, pp. 683-687
-
-
Brinkhous, K.M.1
Smith, H.P.2
Warner, E.D.3
Seegers, W.H.4
-
7
-
-
0013196587
-
Purification of two progressive antithrombins of human plasma
-
Abildgaard U. Purification of two progressive antithrombins of human plasma. Scand J Lab Clin Invest 1967; 19: 190-5.
-
(1967)
Scand J Lab Clin Invest
, vol.19
, pp. 190-195
-
-
Abildgaard, U.1
-
8
-
-
0016186651
-
Identification of two distinct heparin cofactors in human plasma. Separation and partial purification
-
Briginshaw GF, Shanberge UN. Identification of two distinct heparin cofactors in human plasma. Separation and partial purification. Arch Biochem Biophys 1974; 161: 683-90.
-
(1974)
Arch Biochem Biophys
, vol.161
, pp. 683-690
-
-
Briginshaw, G.F.1
Shanberge, U.N.2
-
9
-
-
0019362162
-
Detection of a new Heparin-dependent inhibitor of Thrombin in human plasma
-
Tollefsen DM, Blank MK. Detection of a new Heparin-dependent inhibitor of Thrombin in human plasma J Clin. Invest 1981; 68: 589-96.
-
(1981)
J Clin. Invest
, vol.68
, pp. 589-596
-
-
Tollefsen, D.M.1
Blank, M.K.2
-
10
-
-
0020321012
-
Heparin cofactor II. Purification and properties of a heparin dependent inhibitor of thrombin in human plasma
-
Tollefsen DM, Majerus DW, Blank MK. Heparin cofactor II. Purification and properties of a heparin dependent inhibitor of thrombin in human plasma. J Biol Chem 1982; 257: 2162-9.
-
(1982)
J Biol Chem
, vol.257
, pp. 2162-2169
-
-
Tollefsen, D.M.1
Majerus, D.W.2
Blank, M.K.3
-
11
-
-
0024297509
-
Heparin Cofactor II: CDNA sequence, chromosome localisation, restriction fragment length polymorphism, and expression in Escherichia coli
-
Blinder MA, Marasa JC, Reynolds CH, Deaven LL, Tollefsen DM. Heparin Cofactor II: cDNA sequence, chromosome localisation, restriction fragment length polymorphism, and expression in Escherichia coli. Biochemistry 1988; 27: 752-9.
-
(1988)
Biochemistry
, vol.27
, pp. 752-759
-
-
Blinder, M.A.1
Marasa, J.C.2
Reynolds, C.H.3
Deaven, L.L.4
Tollefsen, D.M.5
-
12
-
-
0022374651
-
Turnover study of Heparin Cofactor II in healthy man
-
Sié P, Dupouy D, Pichon J, Boneu B. Turnover study of Heparin Cofactor II in healthy man. Thromb Haemost 1985; 54 (3): 635-8.
-
(1985)
Thromb Haemost
, vol.54
, Issue.3
, pp. 635-638
-
-
Sié, P.1
Dupouy, D.2
Pichon, J.3
Boneu, B.4
-
13
-
-
0025891865
-
Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11
-
Herzog R, Lutz S, Blin N, Marasa JC, Blinder MA, Tollefsen DM. Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11. Biochemistry 1991; 30. 1350-7.
-
(1991)
Biochemistry
, vol.30
, pp. 1350-1357
-
-
Herzog, R.1
Lutz, S.2
Blin, N.3
Marasa, J.C.4
Blinder, M.A.5
Tollefsen, D.M.6
-
14
-
-
0025195240
-
Substitution of arginine for leucine 444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition
-
Derechin VM, Blinder MA, Tollefsen DM. Substitution of arginine for leucine 444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition. J Biol Chem 1990; 265: 5623-8.
-
(1990)
J Biol Chem
, vol.265
, pp. 5623-5628
-
-
Derechin, V.M.1
Blinder, M.A.2
Tollefsen, D.M.3
-
15
-
-
0025230672
-
On the activation of human leuserpin 2. A thrombin inhibitor by glycosaminoglycans
-
Ragg H, Ulshofer T, Gerewitz J. On the activation of human leuserpin 2. A thrombin inhibitor by glycosaminoglycans. J Biol Chem 1990; 265: 5211 -8.
-
(1990)
J Biol Chem
, vol.265
, pp. 5211-5218
-
-
Ragg, H.1
Ulshofer, T.2
Gerewitz, J.3
-
16
-
-
0028264056
-
The interaction of glycosaminoglycans with heparin cofactor II
-
Tollefsen DM. The interaction of Glycosaminoglycans with heparin cofactor II. Annals New York Academy of Sciences 1994; 714: 21-31.
-
(1994)
Annals New York Academy of Sciences
, vol.714
, pp. 21-31
-
-
Tollefsen, D.M.1
-
18
-
-
0023695042
-
Antithrombotic action of phosvitin and other phosphate containing polyaniones is mediated by heparin cofactor II
-
Church FC, Pratt CW, Treanor RE, Whinna HC. Antithrombotic action of phosvitin and other phosphate containing polyaniones is mediated by heparin cofactor II. FEBS Lett 1988; 237: 26-30.
-
(1988)
FEBS Lett
, vol.237
, pp. 26-30
-
-
Church, F.C.1
Pratt, C.W.2
Treanor, R.E.3
Whinna, H.C.4
-
19
-
-
0024544241
-
Antithrombin activity of fucoidan: The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin
-
Church FC, Meade JB, Treanor RE, Whinna HC. Antithrombin activity of fucoidan: the interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin. J Biol Chem 1989; 264: 3618-23.
-
(1989)
J Biol Chem
, vol.264
, pp. 3618-3623
-
-
Church, F.C.1
Meade, J.B.2
Treanor, R.E.3
Whinna, H.C.4
-
20
-
-
0028793236
-
Selective activation of heparin cofactor II by a sulfated polysaccharide isolates from the leaves of Artemisia princeps
-
Hayakawa Y, Hayashi Toshimitsu, Hayashi Tomohiro, Niiya K, Sakuragawa N. Selective activation of heparin cofactor II by a sulfated polysaccharide isolates from the leaves of Artemisia princeps. Blood Coag Fibrinol 1995; 6: 643-9.
-
(1995)
Blood Coag Fibrinol
, vol.6
, pp. 643-649
-
-
Hayakawa, Y.1
Hayashi, T.2
Hayashi, T.3
Niiya, K.4
Sakuragawa, N.5
-
21
-
-
0021229689
-
Activation of heparin cofactor II by heparin and dermatan sulfate
-
Tollefsen DM. Activation of heparin cofactor II by heparin and dermatan sulfate. Nouv Rev Fr Hematol 1984; 26. 233-7.
-
(1984)
Nouv Rev Fr Hematol
, vol.26
, pp. 233-237
-
-
Tollefsen, D.M.1
-
22
-
-
0025329390
-
The structure of a complex of recombinant hirudin and human alpha thrombin
-
Rydel TJ, Ravichandran KG, Tulinsky A, Bode W, Huber R, Roistsch C, Fenton JWII. The structure of a complex of recombinant hirudin and human alpha thrombin. Science 1990; 249: 277-80.
-
(1990)
Science
, vol.249
, pp. 277-280
-
-
Rydel, T.J.1
Ravichandran, K.G.2
Tulinsky, A.3
Bode, W.4
Huber, R.5
Roistsch, C.6
Fenton J.W. II7
-
23
-
-
0027502741
-
Mutagenesis of thrombin selectively modulates inhibition by serpins Heparin Cofactor II and Antithrombin III
-
Sheehan JP, Wu Q, Tollefsen DM, Sadler JE. Mutagenesis of thrombin selectively modulates inhibition by serpins Heparin Cofactor II and Antithrombin III. J Biol Chem 1993; 268: 3639-45.
-
(1993)
J Biol Chem
, vol.268
, pp. 3639-3645
-
-
Sheehan, J.P.1
Wu, Q.2
Tollefsen, D.M.3
Sadler, J.E.4
-
24
-
-
0028784386
-
Insight into the mechanism of action of heparin cofactor II
-
Tollefsen DM. Insight into the mechanism of action of heparin cofactor II. Thromb Haemost 1995; 74 (5): 1209-14.
-
(1995)
Thromb Haemost
, vol.74
, Issue.5
, pp. 1209-1214
-
-
Tollefsen, D.M.1
-
25
-
-
0028556587
-
Heparin Cofactor II is regulated allosterically and not primarily by templates effects: Studies with mutant thrombins and glycosaminoglycans
-
Sheehan JP, Tollefsen DM, Sadler JE. Heparin Cofactor II is regulated allosterically and not primarily by templates effects: studies with mutant thrombins and glycosaminoglycans. J Biol Chem 1994; 269: 32747-51.
-
(1994)
J Biol Chem
, vol.269
, pp. 32747-32751
-
-
Sheehan, J.P.1
Tollefsen, D.M.2
Sadler, J.E.3
-
26
-
-
0020108082
-
Further characterization of the antithrombin-binding sequence in heparin
-
Thumberg L, Backstrom G, Lindahl U. Further characterization of the antithrombin-binding sequence in heparin. Carbohydr Res 1982; 100: 393-410.
-
(1982)
Carbohydr Res
, vol.100
, pp. 393-410
-
-
Thumberg, L.1
Backstrom, G.2
Lindahl, U.3
-
27
-
-
0026645842
-
Role of protein conformational changes, surface approximation and proteins cofactors in heparinaccelerated antithrombin-proteinase reactions
-
Lane D.A., Björk I, Lindahl U., eds. New York: Plenum Press
-
Olson ST, Björk I. Role of protein conformational changes, surface approximation and proteins cofactors in heparinaccelerated antithrombin-proteinase reactions. In: Lane D.A., Björk I, Lindahl U., eds. Heparin and related polysaccharides Vol 313. New York: Plenum Press, 1992; p 155-65.
-
(1992)
Heparin and Related Polysaccharides
, vol.313
, pp. 155-165
-
-
Olson, S.T.1
Björk, I.2
-
28
-
-
0026788099
-
A comparation of three heparin-binding serine protease inhibitors
-
Prat CW, Whinna HC, Church FC. A comparation of three heparin-binding serine protease inhibitors. J Biol Chem 1992; 267: 8795-801.
-
(1992)
J Biol Chem
, vol.267
, pp. 8795-8801
-
-
Prat, C.W.1
Whinna, H.C.2
Church, F.C.3
-
29
-
-
0028109413
-
Antithrombin: The principal inhibitor of thrombin
-
Olds RJ, Lane DA, Mille B, Chowdhury V, Lay Thein S. Antithrombin: the principal inhibitor of thrombin. Seminars in Thrombosis and Hemostasis 1994; 20: 353-72.
-
(1994)
Seminars in Thrombosis and Hemostasis
, vol.20
, pp. 353-372
-
-
Olds, R.J.1
Lane, D.A.2
Mille, B.3
Chowdhury, V.4
Lay Thein, S.5
-
30
-
-
0029066072
-
Evidence that meizothrombin is an intermediate product in the clotting of whole blood
-
Bovill EG, Tracy RP, Hayes TE, Jenny RJ, Bhushan FH, Mann KG. Evidence that meizothrombin is an intermediate product in the clotting of whole blood. Arterioscler Thromb Vasc Biol 1995; 12: 754-8.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.12
, pp. 754-758
-
-
Bovill, E.G.1
Tracy, R.P.2
Hayes, T.E.3
Jenny, R.J.4
Bhushan, F.H.5
Mann, K.G.6
-
31
-
-
1842296995
-
Inhibition of meizothrombin and meizothrombin (desF1) by Heparin Cofactor II
-
Han JH, Coté HCF, Tollefsen DM. Inhibition of meizothrombin and meizothrombin (desF1) by Heparin Cofactor II. J Biol Chem 1997; 272: 28660-5.
-
(1997)
J Biol Chem
, vol.272
, pp. 28660-28665
-
-
Han, J.H.1
Coté, H.C.F.2
Tollefsen, D.M.3
-
32
-
-
0028296628
-
Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins
-
Bendayan P, Boccalon H, Dupouy D, Bomeau B. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins. Thromb Haemost 1994; 71: 567-82.
-
(1994)
Thromb Haemost
, vol.71
, pp. 567-582
-
-
Bendayan, P.1
Boccalon, H.2
Dupouy, D.3
Bomeau, B.4
-
33
-
-
0021988905
-
Modulation of heparin cofactor II activity by histidinerich glycoprotein and platelet factor 4
-
Tollefsen DM, Pestka CA. Modulation of heparin cofactor II activity by histidinerich glycoprotein and platelet factor 4. J Clin Invest 1985; 75: 496-501.
-
(1985)
J Clin Invest
, vol.75
, pp. 496-501
-
-
Tollefsen, D.M.1
Pestka, C.A.2
-
34
-
-
0024215074
-
Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thfombin-heparin cofactor II complex
-
Preissner KT, Sie P. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thfombin-heparin cofactor II complex. Thromb Haemosf 1988; 60 (3): 399-406.
-
(1988)
Thromb Haemosf
, vol.60
, Issue.3
, pp. 399-406
-
-
Preissner, K.T.1
Sie, P.2
-
36
-
-
0026787022
-
Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin
-
de Boer HC, Preissner KT, Bouma BN, de Groot PG. Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin. J Biol Chem 1992; 267: 2264-8.
-
(1992)
J Biol Chem
, vol.267
, pp. 2264-2268
-
-
De Boer, H.C.1
Preissner, K.T.2
Bouma, B.N.3
De Groot, P.G.4
-
38
-
-
0025831155
-
Structure and biological role of vitronectin
-
Preissner KT. Structure and biological role of vitronectin. Annu Rev Cell Biol 1991; 7: 275-310.
-
(1991)
Annu Rev Cell Biol
, vol.7
, pp. 275-310
-
-
Preissner, K.T.1
-
39
-
-
0028906349
-
Inhibition of thrombin by antithrornbin III and heparin cofactor II in vivo
-
Liu L, Dewar L, Song Y, Kulczycky M, Blajchman MA, Fenton JWII et al. Inhibition of thrombin by antithrornbin III and heparin cofactor II in vivo. Thromb Haemost 1995; 73 (3): 405-12.
-
(1995)
Thromb Haemost
, vol.73
, Issue.3
, pp. 405-412
-
-
Liu, L.1
Dewar, L.2
Song, Y.3
Kulczycky, M.4
Blajchman, M.A.5
Fenton J.W. II6
-
41
-
-
0021223523
-
Separation of radiolabelled glycosaminoglycan oligosaccharides by poliacrilamide-gel; electrophoresis
-
Hampson IN, Gallagher JY. Separation of radiolabelled glycosaminoglycan oligosaccharides by poliacrilamide-gel; electrophoresis. Biochem J 1984; 221: 697-705.
-
(1984)
Biochem J
, vol.221
, pp. 697-705
-
-
Hampson, I.N.1
Gallagher, J.Y.2
-
42
-
-
0027437939
-
Plasma dermatan sulfate proteoglycan in a patient on chronic hemodialysis
-
Delorme MA, Saees N, Sevick A, Mitchell L, Berry L, Johnston M, Andrew M. Plasma Dermatan sulfate proteoglycan in a patient on chronic hemodialysis. Blood 1993; 82: 3380-5.
-
(1993)
Blood
, vol.82
, pp. 3380-3385
-
-
Delorme, M.A.1
Saees, N.2
Sevick, A.3
Mitchell, L.4
Berry, L.5
Johnston, M.6
Andrew, M.7
-
43
-
-
0026570233
-
An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant women and her fetus
-
Andrew M, Mitchel L, Berry L, Paes B, Delorme M, Ofosu F, Burrows R and Khambalia B. An anticoagulant Dermatan sulfate proteoglycan circulates in the pregnant women and her fetus. J Clin Invest 1992; 89: 321-6.
-
(1992)
J Clin Invest
, vol.89
, pp. 321-326
-
-
Andrew, M.1
Mitchel, L.2
Berry, L.3
Paes, B.4
Delorme, M.5
Ofosu, F.6
Burrows, R.7
Khambalia, B.8
-
44
-
-
0026552167
-
Dermatan sulfate: A safe approach to prevention of postoperative deep vein thrombosis
-
Pradoi P, Meduri F, Cuppini S, Toniato A, Zangrandi F, Polistena P, Gianese F, Maffei Faccioli A. Dermatan sulfate: a safe approach to prevention of postoperative deep vein thrombosis. Br J Surg 1992; 79: 505-9.
-
(1992)
Br J Surg
, vol.79
, pp. 505-509
-
-
Pradoi, P.1
Meduri, F.2
Cuppini, S.3
Toniato, A.4
Zangrandi, F.5
Polistena, P.6
Gianese, F.7
Maffei Faccioli, A.8
-
45
-
-
0026605356
-
A randomised, double-blind, placebo-controlled trial of dermatan sulfate for prevention of deep vein thrombosis in hip fracture
-
Agnelli G, Cosmi B, Di Filippo P, Ranucci V, Veschi F, Lobgetti M, Renga C, Barzi F, Gianese F, Lupattelli L, Rinonpoli E, Nency GG. AR. A randomised, double-blind, placebo-controlled trial of dermatan sulfate for prevention of deep vein thrombosis in hip fracture. Thromb Haemost 1992; 67: 203-8.
-
(1992)
Thromb Haemost
, vol.67
, pp. 203-208
-
-
Agnelli, G.1
Cosmi, B.2
Di Filippo, P.3
Ranucci, V.4
Veschi, F.5
Lobgetti, M.6
Renga, C.7
Barzi, F.8
Gianese, F.9
Lupattelli, L.10
Rinonpoli, E.11
Nency, G.G.12
A, R.13
-
46
-
-
0030003270
-
Glycosaminoglycans: Clinical use
-
Boneu B. Glycosaminoglycans: Clinical use. Sem in Thromb Hemost 1996, 22: 209-12.
-
(1996)
Sem in Thromb Hemost
, vol.22
, pp. 209-212
-
-
Boneu, B.1
-
47
-
-
0021995982
-
Constitutional heparin cofactor II deficiency associated with recurrent thrombosis
-
Sie P, Dupouy D, Pichon J, Boneu B. Constitutional heparin cofactor II deficiency associated with recurrent thrombosis. Lancet 1985; II: 414-6.
-
(1985)
Lancet
, vol.2
, pp. 414-416
-
-
Sie, P.1
Dupouy, D.2
Pichon, J.3
Boneu, B.4
-
49
-
-
0022575429
-
Bobine or human thrombin in amidolytic ATIII assays. Infuence of heparin cofactor II
-
Conard J, Bara L, Horellou MH, Samama MM, Bobine or human thrombin in amidolytic ATIII assays. Infuence of heparin cofactor II. Thromb Res 1986; 41: 873-8.
-
(1986)
Thromb Res
, vol.41
, pp. 873-878
-
-
Conard, J.1
Bara, L.2
Horellou, M.H.3
Samama, M.M.4
-
50
-
-
10544253846
-
Inherited thrombophilia: Part 1
-
Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76 (5): 651-62.
-
(1996)
Thromb Haemost
, vol.76
, Issue.5
, pp. 651-662
-
-
Lane, D.A.1
Mannucci, P.M.2
Bauer, K.A.3
Bertina, R.M.4
Bochkov, N.P.5
Boulyjenkov, V.6
-
51
-
-
0030746618
-
Thrombophilia as a multigenic disorder
-
Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost 1997; 78: 297-301.
-
(1997)
Thromb Haemost
, vol.78
, pp. 297-301
-
-
Seligsohn, U.1
Zivelin, A.2
-
52
-
-
0021995981
-
Association of hereditary heparin cofactor II deficiency with thrombosis
-
Tran TH, Marbet GA, Duckert F. Association of hereditary heparin cofactor II deficiency with thrombosis. Lancet 1985; 11: 413-4.
-
(1985)
Lancet
, vol.11
, pp. 413-414
-
-
Tran, T.H.1
Marbet, G.A.2
Duckert, F.3
-
53
-
-
0025495694
-
Hereditary heparin cofactor II deficiency and thrombosis: Report of six patients belonging to two separate kindreds
-
Simioni P, Lazzaro AR, Coser E, Salmistraro G, Girolami A. Hereditary heparin cofactor II deficiency and thrombosis: report of six patients belonging to two separate kindreds. Blood Coag Fibrinol 1990; 1: 351-6.
-
(1990)
Blood Coag Fibrinol
, vol.1
, pp. 351-356
-
-
Simioni, P.1
Lazzaro, A.R.2
Coser, E.3
Salmistraro, G.4
Girolami, A.5
-
54
-
-
0023543224
-
Hereditary heparin cofactor II deficiency and the risk of development of thrombosis
-
Berina RM, van der Linden IK, Engesser L, Muller HP, Brommer JP. Hereditary heparin cofactor II deficiency and the risk of development of thrombosis. Thromb Haemost 1987; 57: 196-200.
-
(1987)
Thromb Haemost
, vol.57
, pp. 196-200
-
-
Berina, R.M.1
Van der Linden, I.K.2
Engesser, L.3
Muller, H.P.4
Brommer, J.P.5
-
56
-
-
0026538935
-
Hereditary heparin cofactor II deficiency and coronary artery disease
-
Matsuo T, Kario K, Sakamoto S, Yamada T, Miki T, Hirase T, et al. Hereditary heparin cofactor II deficiency and coronary artery disease. Thromb Res 1992; 65: 495-7.
-
(1992)
Thromb Res
, vol.65
, pp. 495-497
-
-
Matsuo, T.1
Kario, K.2
Sakamoto, S.3
Yamada, T.4
Miki, T.5
Hirase, T.6
-
57
-
-
0029806282
-
A Heparin Cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects
-
Bernardi F, Legnani C, Micheletti F, Lunghi B, Ferraresi P, Palareti G, et al. A Heparin Cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects. Thromb Haemost 1996; 76 (4): 505-9.
-
(1996)
Thromb Haemost
, vol.76
, Issue.4
, pp. 505-509
-
-
Bernardi, F.1
Legnani, C.2
Micheletti, F.3
Lunghi, B.4
Ferraresi, P.5
Palareti, G.6
-
58
-
-
0022005847
-
Heparin Cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure
-
Tollefsen DM, Pestka C. Heparin Cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure. Blood 1985;66: 769-74.
-
(1985)
Blood
, vol.66
, pp. 769-774
-
-
Tollefsen, D.M.1
Pestka, C.2
-
59
-
-
0025856283
-
Heparin Cofactor II: Experimental approach to a new assay and clinical results
-
Vinazzer H, Stocker K. Heparin Cofactor II: Experimental approach to a new assay and clinical results. Thrombosis Research 1991; 61: 235-41.
-
(1991)
Thrombosis Research
, vol.61
, pp. 235-241
-
-
Vinazzer, H.1
Stocker, K.2
-
60
-
-
0027408742
-
Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II
-
Porter JB, Young L, Mackie IJ, Marshall L, Machin SJ. Sickle cell disorders and chronic intravascular haemolysis are associated with low plasma heparin cofactor II. British Journal of Haematology 1993; 83: 459-65.
-
(1993)
British Journal of Haematology
, vol.83
, pp. 459-465
-
-
Porter, J.B.1
Young, L.2
Mackie, I.J.3
Marshall, L.4
Machin, S.J.5
-
61
-
-
0024431644
-
Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy
-
Sandset PM, Hellgren M, Uvebrandt M, Bergström H. Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy. Thromb Res 1989; 55: 665-70.
-
(1989)
Thromb Res
, vol.55
, pp. 665-670
-
-
Sandset, P.M.1
Hellgren, M.2
Uvebrandt, M.3
Bergström, H.4
-
62
-
-
0025529012
-
Heparin Cofactor II levels are increased by the use of combined oral contraceptives
-
Mackie IJ, Segal H, Burren T, Gallimore M, Walshe KJ, Robinson G, Machin SJ. Heparin Cofactor II levels are increased by the use of combined oral contraceptives. Blood Coag Fibrinol 1990, 1:647-51.
-
(1990)
Blood Coag Fibrinol
, vol.1
, pp. 647-651
-
-
Mackie, I.J.1
Segal, H.2
Burren, T.3
Gallimore, M.4
Walshe, K.J.5
Robinson, G.6
Machin, S.J.7
-
63
-
-
0027495178
-
Heparin cofactor II deficiency in patients infected with the human inmmunodeficiency virus
-
Toulon P, Lamine M, Lejev I, Guez T, Holleman ME, Sereni D, Sicard D. Heparin cofactor II deficiency in patients infected with the human inmmunodeficiency virus. Thromb Haemost 1993; 70: 730-5.
-
(1993)
Thromb Haemost
, vol.70
, pp. 730-735
-
-
Toulon, P.1
Lamine, M.2
Lejev, I.3
Guez, T.4
Holleman, M.E.5
Sereni, D.6
Sicard, D.7
-
65
-
-
0345265247
-
-
Tesis doctoral de Pierre Sie. Université Paris VII. Uer Medicine St Louis. Lariboisière
-
Toulon P, Vitoux JF, Capron L, Roncato M, Fiessinger JN, Aiach M. heparin Cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy. Tesis doctoral de Pierre Sie. Université Paris VII. Uer Medicine St Louis. Lariboisière.
-
Heparin Cofactor II in Patients with Deep Venous Thrombosis under Heparin and Oral Anticoagulant Therapy
-
-
Toulon, P.1
Vitoux, J.F.2
Capron, L.3
Roncato, M.4
Fiessinger, J.N.5
Aiach, M.6
-
66
-
-
0344402252
-
Diabetes mellitus as a prethrombotic state: Both heparin cofactor II (HCII) and antithrombin III (ATIII) were depresed in diabetes mellitus
-
abstract
-
Matsuo T, Kobayashi H, Kadowaki S. Diabetes mellitus as a prethrombotic state: both heparin cofactor II (HCII) and antithrombin III (ATIII) were depresed in diabetes mellitus. Thromb Haemost 1989; 62: 1442 (abstract).
-
(1989)
Thromb Haemost
, vol.62
, pp. 1442
-
-
Matsuo, T.1
Kobayashi, H.2
Kadowaki, S.3
-
67
-
-
0345265245
-
Recomendación aprobada sobre teoría de los valores de referenda
-
Recomendación aprobada sobre teoría de los valores de referenda Acta Bioquímica Clínica Latinoamericana, 1988, XXII (3): 443.
-
(1988)
Acta Bioquímica Clínica Latinoamericana
, vol.22
, Issue.3
, pp. 443
-
-
-
68
-
-
0029837881
-
The VITA proyect: Population-based distributions of Protein C. Antithrombin III. Heparin cofactor II and Plasminogen relationship with physiological variables and establishment of reference ranges
-
Rodeghiero F, Tosetto A. The VITA proyect: population-based distributions of Protein C. Antithrombin III. Heparin cofactor II and Plasminogen relationship with physiological variables and establishment of reference ranges. Thromb Haemost 1996; 76: 226-33.
-
(1996)
Thromb Haemost
, vol.76
, pp. 226-233
-
-
Rodeghiero, F.1
Tosetto, A.2
-
69
-
-
0021194193
-
Heparin cofactor II determination levels in normal and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation
-
Tran TH, Duckert F. Heparin cofactor II determination levels in normal and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation. Thromb Haemost 1984; 52: 112-6.
-
(1984)
Thromb Haemost
, vol.52
, pp. 112-116
-
-
Tran, T.H.1
Duckert, F.2
-
70
-
-
0022654927
-
Heparin cofactor II activity in plasma: Application of an automated assay method to the study of a normal adult population
-
Anderson TR, Larsen ML, Handeland GF, Abildgaard U. Heparin cofactor II activity in plasma: application of an automated assay method to the study of a normal adult population. Scand J Haematol 1986; 36: 96-102.
-
(1986)
Scand J Haematol
, vol.36
, pp. 96-102
-
-
Anderson, T.R.1
Larsen, M.L.2
Handeland, G.F.3
Abildgaard, U.4
-
71
-
-
0021176502
-
Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma
-
Abildgaard U, Larsen ML. Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma. Thromb Res 1984; 35: 257-66.
-
(1984)
Thromb Res
, vol.35
, pp. 257-266
-
-
Abildgaard, U.1
Larsen, M.L.2
-
72
-
-
0023604954
-
Antithrombin III and Heparin Cofactor II in patients with chronic renal failure undergoing regular hemodialysis
-
Toulon P, Jacquot C, Capron L, Frydman MO, Vignon D, Aiach M. Antithrombin III and Heparin Cofactor II in patients with chronic renal failure undergoing regular hemodialysis. Thromb Haemost 1987.
-
(1987)
Thromb Haemost
-
-
Toulon, P.1
Jacquot, C.2
Capron, L.3
Frydman, M.O.4
Vignon, D.5
Aiach, M.6
-
73
-
-
0344833809
-
Measurement of Heparin Cofactor II levels in human plasma
-
Griffith MJ, Thompson GF, McNeely TB, Marbet GA, White GC. Measurement of Heparin Cofactor II levels in human plasma. Circulation 1984; 70: 361.
-
(1984)
Circulation
, vol.70
, pp. 361
-
-
Griffith, M.J.1
Thompson, G.F.2
McNeely, T.B.3
Marbet, G.A.4
White, G.C.5
-
74
-
-
21344445452
-
Cofactor II de la heparina, valores de referencia, consumo en presencia de distintos glicosaminoglicanos
-
Duboscq C, Quintana I, Rossi E, Kordich L. Cofactor II de la Heparina, valores de referencia, consumo en presencia de distintos glicosaminoglicanos. Acta Bioquímica Clínica Latinoamericana 1995; XXIX, 4: 485-92.
-
(1995)
Acta Bioquímica Clínica Latinoamericana
, vol.29
, Issue.4
, pp. 485-492
-
-
Duboscq, C.1
Quintana, I.2
Rossi, E.3
Kordich, L.4
-
75
-
-
0026710191
-
Definition for sepsis an organ failure and guidelines for the use of innovative therapies in sepsis
-
ACCP/SCCM consensus conference
-
ACCP/SCCM consensus conference. Definition for sepsis an organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644.
-
(1992)
Chest
, vol.101
, pp. 1644
-
-
-
76
-
-
0344402264
-
Modificación de los factores de coagulación y ATIII por acción de enzimas leucocitarias
-
Kordich L, Sassetti B, Lago O. Modificación de los factores de coagulación y ATIII por acción de enzimas leucocitarias. Medicina (Buenos Aires) 1978; 38: 840-4.
-
(1978)
Medicina (Buenos Aires)
, vol.38
, pp. 840-844
-
-
Kordich, L.1
Sassetti, B.2
Lago, O.3
|